BC
NPTN

Bridgefront Capital’s NEOPHOTONICS CORP NPTN Stock Holding History

Bridgefront Capital’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-30,340
Closed -$276K – 981
2020
Q4 		$276K Buy
+30,340
New +$235K 0.09% 402

Other funds holding NPTN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Bridgefront Capital's NPTN Position: Q1 2021 in Review

Bridgefront Capital sold out of NEOPHOTONICS CORP (NPTN) in Q1 2021, closing a stake of 30,340 shares — an estimated $276K sold.

Bridgefront Capital first reported a position in NPTN in Q4 2020 and held it in 1 quarter. The position peaked at $276K in Q4 2020. 147 funds tracked by Wall St. Rank hold NPTN as of Q1 2021.

  • Bridgefront Capital reported no remaining NEOPHOTONICS CORP position as of Q1 2021 after selling out during the quarter.
  • Bridgefront Capital sold 30,340 NEOPHOTONICS CORP shares in Q1 2021, an estimated $276K.
  • Bridgefront Capital first reported a position in NEOPHOTONICS CORP in Q4 2020 and held it in 1 quarter.
  • Bridgefront Capital's NEOPHOTONICS CORP position peaked at $276K in Q4 2020.
  • 147 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2021.

Based on Bridgefront Capital's 13F filing for Q1 2021, filed 17 May 2021.